Design Therapeutics (DSGN) Equity Ratio (2020 - 2021)
Design Therapeutics' Equity Ratio history spans 2 years, with the latest figure at 0.98 for Q3 2021.
- For Q3 2021, Equity Ratio changed N/A year-over-year to 0.98; the TTM value through Sep 2021 reached 0.98, changed N/A, while the annual FY2020 figure was 0.31, N/A changed from the prior year.
- Equity Ratio for Q3 2021 was 0.98 at Design Therapeutics, down from 0.99 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.99 in Q2 2021 and bottomed at 0.31 in Q4 2020.